A complete workflow for high-resolution spectral-stitching nanoelectrospray direct-infusion mass-spectrometry-based metabolomics and lipidomics

Nature Protocols

Volumn 12, Issue 2, 2017, Pages 255-273

  Southam, Andrew D ^a   Weber, Ralf J M ^a   Engel, Jasper ^a   Jones, Martin R ^a   Viant, Mark R ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ARTICLE; COST BENEFIT ANALYSIS; DATA PROCESSING; DIRECT INFUSION MASS SPECTROMETRY; ELECTROSPRAY; INFORMATION PROCESSING; LIPIDOMICS; MASS SPECTROMETRY; METABOLOMICS; QUALITY CONTROL; REPRODUCIBILITY; SENSITIVITY ANALYSIS; SPECTRAL STITCHING; STATISTICAL ANALYSIS; WORKFLOW; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; LIPID METABOLISM; NANOTECHNOLOGY; PROCEDURES; TUMOR CELL LINE;

CELL LINE, TUMOR; HUMANS; LIPID METABOLISM; METABOLOMICS; NANOTECHNOLOGY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 85010931968     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2016.156     Document Type: Article

References (72)

1. Fiehn, O. Metabolomics-the link between genotypes and phenotypes. Plant Mol. Biol. 48, 155-171 (2002).
2. Nicholson, J.K., Connelly, J., Lindon, J.C. & Holmes, E. Metabonomics: a platform for studying drug toxicity and gene function. Nat. Rev. Drug Discov. 1, 153-161 (2002).
3. Han, X.L. & Gross, R.W. Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples. Mass Spectrom. Rev. 24, 367-412 (2005).
4. Wenk, M.R. The emerging field of lipidomics. Nat. Rev. Drug Discov. 4, 594-610 (2005).
5. Quehenberger, O. et al. Lipidomics reveals a remarkable diversity of lipids in human plasma. J. Lipid Res. 51, 3299-3305 (2010).
6. Sreekumar, A. et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457, 910-914 (2009).
7. Southam, A.D. et al. Drug redeployment to kill leukemia and lymphoma cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids. Cancer Res. 75, 2530-2540 (2015).
8. Allen, J. et al. High-throughput classification of yeast mutants for functional genomics using metabolic footprinting. Nat. Biotechnol. 21, 692-696 (2003).
9. Kamphorst, J.J. et al. Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. Cancer Res. 75, 544-553 (2015).
10. Taylor, N.S. et al. A new approach to toxicity testing in Daphnia magna: application of high throughput FT-ICR mass spectrometry metabolomics. Metabolomics 5, 44-58 (2009).
11. Southam, A.D. et al. Metabolomics reveals target and off-target toxicities of a model organophosphate pesticide to roach (Rutilus rutilus): implications for biomonitoring. Environ. Sci. Tech. 45, 3759-3767 (2011).
12. Gruening, N.-M. et al. Pyruvate kinase triggers a metabolic feedback loop that controls redox metabolism in respiring cells. Cell Metab. 14, 415-427 (2011).
13. Li, X., Gianoulis, T.A., Yip, K.Y., Gerstein, M. & Snyder, M. Extensive in vivo metabolite-protein interactions revealed by large-scale systematic analyses. Cell 143, 639-650 (2010).
14. Kaelin, W.G. Jr. & McKnight, S.L. Influence of metabolism on epigenetics and disease. Cell 153, 56-69 (2013).
15. Dunn, W.B., Bailey, N.J.C. & Johnson, H.E. Measuring the metabolome: current analytical technologies. Analyst 130, 606-625 (2005).
16. Want, E.J., Cravatt, B.F. & Siuzdak, G. The expanding role of mass spectrometry in metabolite profiling and characterization. Chembiochem 6, 1941-1951 (2005).
17. Jonsson, P. et al. High-throughput data analysis for detecting and identifying differences between samples in GC/MS-based metabolomic analyses. Anal. Chem. 77, 5635-5642 (2005).
18. Theodoridis, G., Gika, H.G. & Wilson, I.D. LC-MS-based methodology for global metabolite profiling in metabonomics/metabolomics. Trac-Trends Anal. Chem. 27, 251-260 (2008).
19. Ramautar, R., Somsen, G.W. & de Jong, G.J. CE-MS for metabolomics: developments and applications in the period 2010-2012. Electrophoresis 34, 86-98 (2013).
20. Koulman, A. et al. High-resolution extracted ion chromatography, a new tool for metabolomics and lipidomics using a second-generation orbitrap mass spectrometer. Rapid Commun. Mass Spectrom. 23, 1411-1418 (2009).
21. Castrillo, J.I., Hayes, A., Mohammed, S., Gaskell, S.J. & Oliver, S.G. An optimized protocol for metabolome analysis in yeast using direct infusion electrospray mass spectrometry. Phytochemistry 62, 929-937 (2003).
22. Beckmann, M., Parker, D., Enot, D.P., Duval, E. & Draper, J. High-throughput, nontargeted metabolite fingerprinting using nominal mass flow injection electrospray mass spectrometry. Nat. Protoc. 3, 486-504 (2008).
23. Southam, A.D., Payne, T.G., Cooper, H.J., Arvanitis, T.N. & Viant, M.R. Dynamic range and mass accuracy of wide-scan direct infusion nanoelectrospray Fourier transform ion cyclotron resonance mass spectrometry-based metabolomics increased by the spectral stitching method. Anal. Chem. 79, 4595-4602 (2007).
24. Weber, R.J.M., Southam, A.D., Sommer, U. & Viant, M.R. Characterization of isotopic abundance measurements in high resolution FT-ICR and Orbitrap mass spectra for improved confidence of metabolite identification. Anal. Chem. 83, 3737-3743 (2011).
25. Hop, C., Chen, Y. & Yu, L.J. Uniformity of ionization response of structurally diverse analytes using a chip-based nanoelectrospray ionization source. Rapid Commun. Mass Spectrom. 19, 3139-3142 (2005).
26. Kind, T. & Fiehn, O. Metabolomic database annotations via query of elemental compositions: Mass accuracy is insufficient even at less than 1 ppm. BMC Bioinformatics 7, 234 (2006).
27. Sumner, L.W. et al. Proposed minimum reporting standards for chemical analysis. Metabolomics 3, 211-221 (2007).
28. Davidson, R.L., Weber, R.J.M., Liu, H., Sharma-Oates, A. & Viant, M.R. Galaxy-M: a Galaxy workflow for processing and analysing direct infusion and liquid chromatography mass spectrometry-based metabolomics data. Gigascience 5, 10 (2015).
29. Kirwan, J.A., Weber, R.J.M., Broadhurst, D.I. & Viant, M.R. Direct infusion mass spectrometry metabolomics dataset: a benchmark for data processing and quality control. Sci. Data 1, 140012 (2014).
30. Hao, J. et al. Statistical correlations between NMR spectroscopy and direct infusion FT-ICR mass spectrometry aid annotation of unknowns in metabolomics. Anal. Chem. 88, 2583-2589 (2016).
31. Lin, L. et al. Direct infusion mass spectrometry or liquid chromatography mass spectrometry for human metabonomics? A serum metabonomic study of kidney cancer. Analyst 135, 2970-2978 (2010).
32. Annesley, T.M. Ion suppression in mass spectrometry. Clin. Chem. 49, 1041-1044 (2003).
33. Schmidt, A., Karas, M. & Dulcks, T. Effect of different solution flow rates on analyte ion signals in nano-ESI MS, or: when does ESI turn into nano-ESI? J. Am. Soc. Mass Spectrom. 14, 492-500 (2003).
34. Yang, K. & Han, X. Accurate quantification of lipid species by electrospray ionization mass spectrometry-meets a key challenge in lipidomics. Metabolites 1, 21-40 (2011).
35. Poynton, H.C. et al. Metabolomics of microliter hemolymph samples enables an improved understanding of the combined metabolic and transcriptional responses of Daphnia magna to cadmium. Environ. Sci. Tech. 45, 3710-3717 (2011).
36. Gonzalez-Dominguez, R., Castilla-Quintero, R., Garcia-Barrera, T. & Luis Gomez-Ariza, J. Development of a metabolomic approach based on urine samples and direct infusion mass spectrometry. Anal. Biochem. 465, 20-27 (2014).
37. Lokhov, P.G. et al. Prediction of classical clinical chemistry parameters using a direct infusion mass spectrometry. International Journal of Mass Spectrometry http://dx.doi.org/10.1016/j.ijms.2015.08.006 (2015).
38. Drury, N.E. et al. The effect of perhexiline on myocardial protection during coronary artery surgery: a two-centre, randomized, double-blind, placebo-controlled trial. Eur. J. Cardio-Thorac. Surg. 47, 464-472 (2015).
39. Mirbahai, L. et al. Disruption of DNA methylation via S-adenosylhomocysteine is a key process in high incidence liver carcinogenesis in fish. J. Proteome Res. 12, 2895-2904 (2013).
40. Weber, R.J.M., Selander, E., Sommer, U. & Viant, M.R. A stable-isotope mass spectrometry-based metabolic footprinting approach to analyze exudates from phytoplankton. Mar. Drugs 11, 4158-4175 (2013).
41. Southam, A.D. et al. Distinguishing between the metabolome and xenobiotic exposome in environmental field samples analysed by direct-infusion mass spectrometry based metabolomics and lipidomics. Metabolomics 10, 1050-1058 (2014).
42. Sturla, S.J. et al. Systems toxicology: from basic research to risk assessment. Chem. Res. Toxicol. 27, 314-329 (2014).
43. Van Aggelen, G. et al. Integrating omic technologies into aquatic ecological risk assessment and environmental monitoring: hurdles, achievements, and future outlook. Environ. Health Perspect. 118, 1-5 (2010).
44. Parsons, H.M., Ekman, D.R., Collette, T.W. & Viant, M.R. Spectral relative standard deviation: a practical benchmark in metabolomics. Analyst 134, 478-485 (2009).
45. Sellick, C.A., Hansen, R., Stephens, G.M., Goodacre, R. & Dickson, A.J. Metabolite extraction from suspension-cultured mammalian cells for global metabolite profiling. Nat. Protoc. 6, 1241-1249 (2011).
46. Taylor, N.S., Weber, R.J.M., White, T.A. & Viant, M.R. Discriminating between different acute chemical toxicities via changes in the Daphnid metabolome. Toxicol. Sci. 118, 307-317 (2010).
47. Want, E.J. et al. Global metabolic profiling of animal and human tissues via UPLC-MS. Nat. Protoc. 8, 17-32 (2013).
48. Want, E.J. et al. Global metabolic profiling procedures for urine using UPLC-MS. Nat. Protoc. 5, 1005-1018 (2010).
49. Dunn, W.B. et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat. Protoc. 6, 1060-1083 (2011).
50. Wu, H., Southam, A.D., Hines, A. & Viant, M.R. High-throughput tissue extraction protocol for NMR-and MS-based metabolomics. Anal. Biochem. 372, 204-212 (2008).
51. Lin, C.Y., Wu, H.F., Tjeerdema, R.S. & Viant, M.R. Evaluation of metabolite extraction strategies from tissue samples using NMR metabolomics. Metabolomics 3, 55-67 (2007).
52. Han, X., Yang, K. & Gross, R.W. Multi-dimensional mass spectrometry-based shotgun lipidomics and novel strategies for lipidomic analyses. Mass Spectrome. Rev. 31, 134-178 (2012).
53. Bligh, E.G. & Dyer, W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911-917 (1959).
54. Matyash, V., Liebisch, G., Kurzchalia, T.V., Shevchenko, A. & Schwudke, D. Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J. Lipid Res. 49, 1137-1146 (2008).
55. Schultz, G.A., Corso, T.N., Prosser, S.J. & Zhang, S. A fully integrated monolithic microchip electrospray device for mass spectrometry. Anal. Chem. 72, 4058-4063 (2000).
56. Zhang, L.K., Rempel, D., Pramanik, B.N. & Gross, M.L. Accurate mass measurements by Fourier transform mass spectrometry. Mass Spectrom. Rev. 24, 286-309 (2005).
57. Payne, T.G., Southam, A.D., Arvanitis, T.N. & Viant, M.R. A signal filtering method for improved quantification and noise discrimination in Fourier transform ion cyclotron resonance mass spectrometry-based metabolomics data. J. Am. Soc. Mass Spectrom. 20, 1087-1095 (2009).
58. Dieterle, F., Ross, A., Schlotterbeck, G. & Senn, H. Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in H-1 NMR metabonomics. Anal. Chem. 78, 4281-4290 (2006).
59. Kirwan, J.A., Broadhurst, D.I., Davidson, R.L. & Viant, M.R. Characterising and correcting batch variation in an automated direct infusion mass spectrometry (DIMS) metabolomics workflow. Anal. Bioanal. Chem. 405, 5147-5157 (2013).
60. Hrydziuszko, O. & Viant, M.R. Missing values in mass spectrometry based metabolomics: an undervalued step in the data processing pipeline. Metabolomics 8, S161-S174 (2012).
61. Parsons, H.M., Ludwig, C., Gunther, U.L. & Viant, M.R. Improved classification accuracy in 1-and 2-dimensional NMR metabolomics data using the variance stabilising generalised logarithm transformation. BMC Bioinformatics 8, 16 (2007).
62. van den Berg, R.A., Hoefsloot, H.C.J., Westerhuis, J.A., Smilde, A.K. & van der Werf, M.J. Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics 7, 142 (2006).
63. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate-a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57, 289-300 (1995).
64. Good, P.L. Permutation, Parametric, and Bootstrap Tests of Hypotheses (Springer, 2005).
65. Szymanska, E., Saccenti, E., Smilde, A.K. & Westerhuis, J.A. Double-check: validation of diagnostic statistics for PLS-DA models in metabolomics studies. Metabolomics 8, 3-16 (2012).
66. Dunn, W.B. et al. Mass appeal: metabolite identification in mass spectrometry-focused untargeted metabolomics. Metabolomics 9, S44-S66 (2013).
67. Weber, R.J.M. & Viant, M.R. MI-Pack: increased confidence of metabolite identification in mass spectra by integrating accurate masses and metabolic pathways. Chemometrics Intell. Lab. Syst. 104, 75-82 (2010).
68. Kind, T. & Fiehn, O. Seven Golden Rules for heuristic filtering of molecular formulas obtained by accurate mass spectrometry. BMC Bioinformatics 8, 105 (2007).
69. Haug, K. et al. MetaboLights-an open-access general-purpose repository for metabolomics studies and associated meta-data. Nucleic Acids Res. 41, D781-D786 (2013).
70. Sud, M. et al. Metabolomics Workbench: an international repository for metabolomics data and metadata, metabolite standards, protocols, tutorials and training, and analysis tools. Nucleic Acids Res. 44, D463-D470 (2015).
71. Bennett, B.D., Yuan, J., Kimball, E.H. & Rabinowitz, J.D. Absolute quantitation of intracellular metabolite concentrations by an isotope ratio-based approach. Nat. Protoc. 3, 1299-1311 (2008).
72. Taylor, N.S. et al. Metabolomics confirms that dissolved organic carbon mitigates copper toxicity. Environ. Toxicol. Chem. 35, 635-644 (2015).